Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older, of any gender
- People who have a documented history of atrial fibrillation (an irregular heartbeat condition)
- People who are able to sign and provide written consent to participate
Who may not be able to join:
- People who have a moderate or severe narrowing of the mitral heart valve, or who have a mechanical (artificial) heart valve
- People who have previously had, or who are planning to have, a procedure to treat atrial fibrillation using heat or cold energy (ablation)
- People who have previously had, or who are planning to have, a procedure to close off a small pouch in the heart called the left atrial appendage
- People who would not be able to attend or cooperate with follow-up appointments after their initial assessment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhe Zheng, MD, PhD, Fuwai Hospital, Chinese Academy of Medical Science
Phone: +86-010-88396051
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite of Stroke and Systemic Embolic Events (SEE)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.